A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INCOMPLETE BLOCK CROSSOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VX-371 SOLUTION FOR INHALATION IN SUBJECTS WITH PRIMARY CILIARY DYSKINESIA

Registry ID
PS-G202
Source registry
HEALTH_CANADA
Status
Ongoing
Phase
PHASE2
Study type
INTERVENTIONAL
Sponsor
PARION SCIENCES INCORPORATED
Start date
2017-11-29
Last update
2016-05-26

Conditions

View on source registry